Shanghai, China, June 10 /Xinhua-PRNewswire/ -- Fresenius Medical Care is offering its assistance to the earthquake victims in the Chinese province of Sichuan. In addition to significant humanitarian aid, the Company has donated a total of $1.1 million in both cash and material goods to help ease the suffering of those affected by the natural disaster. Fresenius Medical Care is providing medical equipment, services and reconstruction assistance to hospitals and aid organizations in the region.
Teams of Fresenius Medical Care employees have delivered, for example, dialysis machines for acute renal therapy to various hospitals in the Sichuan province. The teams, which consisted of logistics experts, technicians, technical engineers and clinical specialists, also supported the rescue operation through the installation and proper usage of the machines. Fresenius Medical Care China is also supporting various aid organizations such as the Hong Kong Kidney Foundation by arranging logistics and other services to ensure vital relief supplies reach hospitals on time.
Roberto Fusté, Chief Executive Officer of Fresenius Medical Care for Asia-Pacific: "The misery and suffering of the victims in China has affected us deeply. We want to help the people there quickly and without much red tape, and have prepared an emergency package. Besides financial support, it primarily contains donations in-kind such as dialysis machines and medical products as well as ample services for the treatment of victims with renal failure in the area hit by the earthquake. The equipment and relief supplies were delivered as soon as we learned about the tragedy. We will also support rebuilding efforts in the area. Our staff in the regions is in close contact with the field help and the responsible authorities."
Fresenius Medical Care is the world's largest integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure, a condition that affects more than 1,600,000 individuals worldwide. Through its network of 2,297 dialysis clinics in North America, Europe, Latin America, Asia-Pacific and Africa, Fresenius Medical Care provides dialysis treatment to 177,059 patients around the globe. Fresenius Medical Care is also the world's leading provider of dialysis products such as hemodialysis machines, dialyzers and related disposable products. Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME, FME3) and the New York Stock Exchange (FMS, FMS/P).
For more information about Fresenius Medical Care visit the Company's website at http://www.fmc-ag.com .
This release contains forward-looking statements that are subject to various risks and uncertainties. Actual results could differ materially from those described in these forward-looking statements due to certain factors, including changes in business, economic and competitive conditions, regulatory reforms, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. These and other risks and uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA's reports filed with the U.S. Securities and Exchange Commission. Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.
Contact:
Helen Zhang
Senior Public Affairs Manager
Tel.: +86-10-6409-6798
Mobile: +86-139-0136-9745
E-mail: helen.zhang@fmc-asia.com
http://www.fmc-ag.com
